Malaria Vaccines 101
Explore the complexities of malaria vaccine development, targeting Plasmodium species/stages, immunity evidence, and broad vaccine approaches focusing on sub-unit vaccines. Discover the quest for an effective and accessible malaria vaccine.
9 views • 32 slides
Addressing Health Inequalities and Vaccine Hesitancy in Shirebrook: Findings and Strategies
Shirebrook, a deprived area in Derbyshire, has been grappling with health inequalities and vaccine hesitancy, particularly among certain groups like ethnic minorities and those living in deprivation. Efforts have been made to engage the community, resulting in varying levels of vaccine uptake among
1 views • 14 slides
Update on Infectious Disease Prevention and H5N1 Vaccine Production
This content provides updates on infectious disease prevention efforts, including historical data, TB data posting schedule, and HIV surveillance updates. It also highlights the plans of the US Department of Health and Human Services to produce 4.8 million doses of the H5N1 avian flu vaccine for pan
0 views • 7 slides
Making Informed Vaccine Decisions for Your 2-Month-Old Infant
Congratulations on your infant reaching 2 months! Learn about the importance of vaccines and how to make informed decisions regarding vaccinating your baby. Access valuable resources from CDC to understand vaccine benefits and risks. Still unsure? Get familiar with vaccine-preventable diseases and h
0 views • 14 slides
Understanding Polio Eradication Efforts and Vaccine Development
Polio, a disabling disease caused by the poliovirus, mainly affects children and can lead to paralysis. Efforts to eradicate polio include the development of vaccines like the Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). The poliovirus' choice of host, ease of transmission, and impa
0 views • 15 slides
Moderna Becomes Third Covid Vaccine Approved in the UK - Important Updates
The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains
0 views • 7 slides
National COVID-19 Vaccine Deployment and Roll-Out Plan in Zimbabwe
The Republic of Zimbabwe is gearing up for the introduction of a COVID-19 vaccine as part of its response to the pandemic, with a focus on deploying 200,000 doses to priority groups. The comprehensive plan includes key strategies, financing alignment, and integration into national governance mechani
5 views • 28 slides
BCG Vaccine: Overview, Administration, and Considerations
BCG vaccine, a live attenuated vaccine, protects against tuberculosis with varying efficacy. It is administered intradermally in the left upper arm, leaving a characteristic scar. Adverse reactions are generally mild, but contraindicated in immunodeficiency or HIV infection.
0 views • 12 slides
Understanding Vaccine Safety, Effectiveness, and Side Effects: A Guide to Better Living
This informative content delves into vaccine safety, effectiveness, and side effects, offering insights into the development stages of vaccines, COVID-19 vaccine comparisons, and an overview of COVID-19 vaccine development. It also explains how vaccines work to protect against viruses and emphasizes
0 views • 33 slides
Installation Guide for VFC-400 Vaccine Monitoring Data Logger Kit
This installation guide provides step-by-step instructions for installing the probe of the VFC-400 Vaccine Monitoring Data Logger Kit in a fridge or freezer. The guide includes details on placing the probe, routing the cable, securing with zip ties, and mounting the logger for efficient monitoring.
0 views • 5 slides
VFC-400 Vaccine Monitoring Data Logger Kit Operations Overview
This presentation provides a detailed guide on operating the VFC-400 Vaccine Monitoring Data Logger Kit. It covers essential functions like entering review mode, starting and stopping recording, and monitoring temperature data. The step-by-step instructions ensure accurate temperature logging for va
0 views • 9 slides
Potential Pyogenic Liver Abscess Case Report in Elderly Female Post COVID-19 Vaccination
An 84-year-old female presented with fever, SOB, fatigue, and diarrhea after receiving a COVID-19 vaccine. Despite initial improvement with antibiotics, she developed liver abscess, highlighting the complexity of diagnosing post-vaccination symptoms. Clinicians should remain vigilant and consider al
0 views • 5 slides
COVID-19 Vaccine Update: Pfizer Vaccine Logistics and Emergency Use Authorization
The update discusses the latest information on Pfizer's COVID-19 vaccine, including details on the new technology, storage requirements, logistics handling, and Emergency Use Authorization (EUA). Pfizer's vaccine, with a 95% efficacy rate, requires storage in ultra-low-temperature freezers or therma
0 views • 28 slides
Co-created Messages & Trusted Messengers for COVID-19 Vaccine Acceptance in Northern Nigeria
Dr. Chizoba Wonodi is evaluating the use of co-created messages and trusted messengers to improve COVID-19 vaccine acceptance in Northern Nigeria. Vaccine hesitancy due to conspiracy theories and safety concerns remains a challenge. TM-COVAC study aims to design targeted messages using human-centere
0 views • 8 slides
VASE+ Release 11.4: New Features for Vaccine Management
In the latest VASE+ Release 11.4, several new features have been introduced to enhance vaccine management processes. These include a new vaccine selection field, Pfizer vaccine lot addition for 5-11-year-olds, color coding per vaccine type, customizability options, new columns for vaccine name and s
0 views • 8 slides
Vaccine Administration Best Practices and Waste Management
This content provides valuable information on handling vaccines, including determining vaccine viability, identifying wastage, and understanding expiration dates. It includes scenarios covering vaccine storage, reporting spoiled doses, and managing vial wastage. The answers and explanations offered
0 views • 7 slides
Understanding the Impact of Vaccine Wastage on Measles Elimination Efforts
This presentation focuses on the significance of vaccine wastage in the context of measles elimination, emphasizing the factors influencing wastage, why it matters for achieving high vaccination coverage, and tools for estimating wastage. The content highlights the challenges posed by wastage on vac
0 views • 13 slides
Interrogating the Establishment of Vaccine Plants in Africa: Case Studies of Rwanda and Uganda
Nimrod Muhumuza, from Afya na Haki Institute, presents a critical analysis of vaccine plant setup in Rwanda and Uganda. The discussion focuses on the potential leadership roles of small economies, private sector involvement, sustainability of vaccine production, and the importance of participation f
0 views • 13 slides
Effect of Efgartigimod on Humoral Vaccine Responses in Patients with Autoimmune Diseases
The study explores the impact of Efgartigimod, a Neonatal Fc Receptor blocker, on humoral vaccine responses in patients with autoimmune diseases. It discusses how immunosuppressive therapies used in autoimmune disorders may affect susceptibility to infections and impair vaccine immunogenicity, highl
0 views • 18 slides
Understanding the COVID-19 Vaccine: Information from Illinois Department of Corrections
The Illinois Department of Corrections emphasizes the importance of the COVID-19 vaccine, highlighting its effectiveness in preventing severe illness. Individuals are encouraged to make an informed decision about vaccination, ensuring protection for themselves and others. The department assures that
0 views • 52 slides
Understanding the Oxford-AstraZeneca Vaccine: Benefits, Risks, and Recommendations
The Oxford-AstraZeneca vaccine has shown a likely but unproven link to cerebral venous sinus thrombus and other blood clotting issues. Despite this, the benefits of vaccination still outweigh the risks, with only approximately 4 cases per million resulting in death. Communication of the potential be
0 views • 10 slides
Key Findings and Recommendations from VET Evaluation July 2022
A presentation of key findings and recommendations from the Vaccine Engagement Teams (VETs) Evaluation in July 2022, highlighting increased vaccine confidence, effective ambassador outreach, and innovative community health programming. The evaluation assessed the VETs' achievements, identified barri
0 views • 19 slides
Update on COVID-19 Vaccine Uptake in Tennessee as of October 8, 2021
In this update, Tennessee reports an increase in COVID-19 vaccine uptake with 52.8% having at least one dose and 46.7% fully immunized. The state ranks 40th in vaccine administration per 100K population. Vaccine hesitancy is addressed, and dates of FDA committee meetings on booster authorizations an
0 views • 15 slides
History of Vaccine Liability and Legal Issues in the United States
This presentation discusses the history of vaccine liability and legal battles in the United States, covering events such as the Cutter Incident, the Swine Flu vaccine campaign, and cases like Berkovitz v. U.S. It explores the challenges, consequences, and legal defenses surrounding vaccine-related
0 views • 25 slides
Alpha Office Hours 6/16/2022 Agenda & Updates
Pfizer and Moderna vaccine updates for different age groups, Novavax administration, clinical updates, and myocarditis/pericarditis updates were discussed in the Alpha Office Hours meeting scheduled for June 16, 2022. The agenda also included Vaccine Finder and July 4th shipping updates. The timelin
0 views • 31 slides
Michigan COVID-19 Vaccine Survey Insights
The Michigan COVID-19 Survey conducted in March 2021 provides valuable insights on vaccine segments, key findings, and likelihood to get the vaccine among residents aged 16 and older. The survey categorizes individuals into Vaccine Definites, Persuadables, and Nevers, highlighting that 61% are firml
1 views • 10 slides
Edward Jenner: Pioneer of Smallpox Vaccine and Father of Immunology
Edward Jenner, a renowned figure in medical history, was born on May 17, 1749. He made significant contributions to immunology by developing the smallpox vaccine. His pioneering work involved inoculating individuals with cowpox to confer immunity against smallpox, a disease that was highly feared fo
0 views • 13 slides
Vaccine Inventory Lot Management Job Aid
This job aid explains how Site Admins can add, edit, and manage vaccine inventory lots for clinics. Users can add new vaccine lots, edit existing entries, and associate vaccine lots with specific clinics in the system. The process involves entering lot details, NDC code, expiration, and available do
0 views • 4 slides
Global Vaccine and Immunization Research Forum 2023 Agenda
The Global Vaccine and Immunization Research Forum 2023, scheduled for March 28-30 at Grand Hyatt, Incheon, Korea, will feature keynote speakers, plenary sessions, workshops, and discussions on various topics related to vaccine research, development, and global health. The agenda includes sessions o
0 views • 9 slides
COVID-19 Vaccination for People Experiencing Homelessness Presentation Overview
This presentation, developed by CDC's COVID-19 Response Vaccine Task Force and Homelessness Unit, focuses on COVID-19 vaccination basics, safety, prioritization for individuals experiencing homelessness, and strategies to overcome barriers to vaccination. It highlights the importance of understandin
0 views • 49 slides
Creating Clinic Schedules in VASE+ System
Learn how to efficiently create clinic schedules in VASE+ system for managing appointments, vaccine information, and site details. Explore step-by-step guidance on setting clinic name, contact points, timing, intervals, and vaccine details. Users with specific roles in the system can easily create s
0 views • 4 slides
Monitoring Chemoprevention Efficacy: Draft CPES Protocol
Contextual guidelines are being reviewed for expanding chemoprevention interventions, highlighting concerns over resistance and efficacy. Therapeutic Efficacy Studies (TES) play a crucial role in monitoring treatment outcomes, but molecular markers of resistance are imperfect predictors of chemoprev
0 views • 8 slides
London Care Home Flu Vaccine Campaign Pack 20/21
This campaign pack provides resources for care home providers in London to increase flu vaccine uptake among staff. It includes key messages, strategies, and tools tailored for engaging with healthcare and social care staff, emphasizing the importance of flu vaccination in light of the COVID-19 pand
0 views • 21 slides
COVID-19 Vaccine Updates and Recommendations - January 2023
New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi
0 views • 6 slides
NC COVID-19 Vaccine Plan Update Oct 9, 2020 Task Force Meeting Overview
The NC COVID-19 Vaccine Plan discussed in the October 9, 2020 Task Force Meeting includes details on vaccine supply, distribution goals, clinical trial timelines, safety, and outreach strategies. Key points cover vaccine development progress, trial protocols, distribution targets, and communication
0 views • 6 slides
Safety and Efficacy of BNT162b2 mRNA Covid-19 Vaccine Phase 3 Data
Phase 3 data of the BNT162b2 mRNA Covid-19 vaccine, including study design, participant groups, primary endpoints, and key findings regarding safety and efficacy. The vaccine demonstrated efficacy against confirmed Covid-19, with reported local and systemic adverse effects within a specified timefra
0 views • 48 slides
Correlation Between Self-Efficacy and Test Performance Based on International Assessment Data
Explore the correlation between self-efficacy, readiness to learn, intrinsic and extrinsic motivation with test performance using data from international assessments like PISA and PIAAC. Learn about the limitations of linear models in psychological research and the debate around self-efficacy accord
0 views • 32 slides
Aging and Disability Vaccine Collaborative (ADVC) Project Overview
The Aging and Disability Vaccine Collaborative (ADVC) led by Tannis Hargrove at the University of Montana aims to support vaccination education and promotion activities for older adults and people with disabilities. Through partnerships with various organizations, the ADVC provides accessible and in
0 views • 12 slides
Introduction of Gardasil HPV Vaccine in Sikkim's Routine Immunization Programme
Cervical cancer is a major health issue in Sikkim, India, prompting the introduction of the Gardasil HPV vaccine to address the high prevalence of HPV infections leading to cervical cancer. The state-wide immunization campaign targeted girls aged 9-14, aiming to incorporate the vaccine into the rout
0 views • 10 slides
Permutation Tests and False Detection Rate in HPV Vaccine Trial
Permutation tests are computer-intensive methods used for hypothesis testing when the distribution of the test statistic is unknown. In a hypothetical HPV vaccine trial with 200 women, the scientific question revolves around comparing infection risks in groups receiving the vaccine and placebo. The
0 views • 19 slides